Factors contributing to the high prevalence of multidrug-resistance/Rifampicin-resistance in patients with tuberculosis: an epidemiological cross sectional and qualitative study from Khabarovsk krai region of Russia
Abstract Background Growing prevalence of multidrug-resistant/Rifampicin-resistant tuberculosis (MDR/RR-TB; resistance to Isoniazid and Rifampicin/Isolated resistance to Rifampicin) is putting in jeopardy the WHO End TB strategy. This study aimed to identify factors contributing to the high prevalen...
Main Authors: | Ilia Bykov, Olga Dyachenko, Pavel Ratmanov, Huan Liu, Libo Liang, Qunhong Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-022-07598-7 |
Similar Items
-
Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
by: Rajendra Prasad, et al.
Published: (2018-01-01) -
Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)
by: Betty R. Mchaki, et al.
Published: (2023-02-01) -
Treatment cascade for patients with multidrug- or rifampicin-resistant tuberculosis and associated factors with patient attrition in southeastern China: a retrospective cohort study
by: Bin Chen, et al.
Published: (2023-07-01) -
Evaluation of the genexpert Mycobacterium tuberculosis/Rifampicin assay for early detection of extrapulmonary tuberculosis and rifampicin resistance in aligarh region of Northern India
by: M D Ahsan Imam, et al.
Published: (2023-01-01) -
Microbiome in sputum as a potential biomarker of chronicity in pulmonary resistant to rifampicin-tuberculosis and multidrug-resistant-tuberculosis patients
by: Nurul Wiqoyah, et al.
Published: (2021-01-01)